SREBF1 and steatosis: Notably, SREBP1 and FASN did not change significantly in the 3D and mouse steatosis models, whereas PGC1A/CPT1A increased in both, consistent with an early metabolic response favoring fatty acid oxidation over robust repression of de novo lipogenesis (Table 1).